Bank of New York Mellon Corp grew its stake in Ventas, Inc. (NYSE:VTR – Free Report) by 2.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,868,962 shares of the real estate investment trust’s stock after buying an additional 70,459 shares during the period. Bank of New York Mellon Corp’s holdings in Ventas were worth $222,000,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in VTR. GoalVest Advisory LLC bought a new stake in shares of Ventas during the 4th quarter valued at about $26,000. Wiser Advisor Group LLC bought a new position in shares of Ventas in the third quarter valued at approximately $27,000. Elyxium Wealth LLC bought a new position in shares of Ventas in the fourth quarter valued at approximately $33,000. True Wealth Design LLC lifted its holdings in shares of Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 138 shares in the last quarter. Finally, AlphaQuest LLC lifted its holdings in Ventas by 1,848.5% during the third quarter. AlphaQuest LLC now owns 643 shares of the real estate investment trust’s stock worth $45,000 after acquiring an additional 610 shares during the period. Institutional investors own 94.18% of the company’s stock.
Insider Activity at Ventas
In related news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.
Ventas Trading Up 3.8%
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the company earned $0.84 EPS. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts predict that Ventas, Inc. will post 3.88 EPS for the current year.
Ventas Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio is 378.18%.
Analyst Ratings Changes
A number of brokerages recently commented on VTR. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Royal Bank Of Canada lifted their price target on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. JPMorgan Chase & Co. lifted their price objective on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Monday, May 11th. Scotiabank lifted their price objective on Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Finally, Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $95.19.
Get Our Latest Research Report on Ventas
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
